Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year

Little is known about the impact of coronavirus disease 2019 (COVID-19) pandemic to the care of patients with systemic lupus erythematosus (SLE) in the long-term. By crossing population data with the results of a web-based survey focused on the timeframes January–April and May–December 2020, we foun...

Full description

Saved in:
Bibliographic Details
Published in:Clinical immunology (Orlando, Fla.) Fla.), 2021-10, Vol.231, p.108845-108845, Article 108845
Main Authors: Ramirez, Giuseppe A., Argolini, Lorenza M., Bellocchi, Chiara, Moroni, Luca, Della-Torre, Emanuel, Farina, Nicola, Caporali, Roberto F., Beretta, Lorenzo, Gerosa, Maria, Bozzolo, Enrica P., Dagna, Lorenzo
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aging
Containment
Coronavirus
COVID-19
COVID-19 - complications
COVID-19 - prevention & control
COVID-19 - transmission
COVID-19 Vaccines - immunology
Data Collection
Female
Full Length
Humans
Immunosuppressive Agents - therapeutic use
Incidence
Lockdown
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - drug therapy
Male
Middle Aged
Prednisone
Public health
SARS-CoV-2
Surveys and Questionnaires
Systemic lupus erythematosus
Treatment
Vaccination
Vaccination Refusal
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Little is known about the impact of coronavirus disease 2019 (COVID-19) pandemic to the care of patients with systemic lupus erythematosus (SLE) in the long-term. By crossing population data with the results of a web-based survey focused on the timeframes January–April and May–December 2020, we found that among 334/518 responders, 28 had COVID-19 in 2020. Seventeen cases occurred in May–December, in parallel with trends in the general population and loosening of containment policy strength. Age > 40 years (p = 0.026), prednisone escalation (p = 0.008) and infected relatives (p 
ISSN:1521-6616
1521-7035
1521-7035
DOI:10.1016/j.clim.2021.108845